AGP Executive Report
Last update: 4 hours agoClinical Updates: The AHA/ASA released its 2026 adult stroke rehabilitation guideline, updating care from hyperacute hospital treatment through long-term community reintegration. Oncology Research: A Norwegian team reported a light-activated therapeutic cancer vaccine in mice, boosting T-cell responses dramatically and driving tumor disappearance. Neurology Case Insight: A new case report links long-term mycophenolate use in AQP4+ NMOSD to an EBV-driven CNS lymphoproliferative disorder, highlighting relapse-vs-complication clues for clinicians. Cancer Care Evidence: Final MATTERHORN results show perioperative durvalumab plus FLOT improved overall survival in resectable gastric/GEJ adenocarcinoma. Mental Health & Lifestyle: A review finds therapeutic gardening can ease depression and anxiety for adults with chronic conditions, while strength training shows large antidepressant effects for young women with anxiety. Public Health & Access: Nigeria’s PHC assessment found 97% of centers miss staffing standards, with major gaps in electricity, water, and neonatal resuscitation equipment. Safety Alert: American Regent recalled epinephrine injection lots due to particulate matter and cracked vials. Care Delivery/Workforce: West Virginia’s grant will expand a workforce health model via Marshall Health Network, aiming to reduce barriers to employment and improve chronic disease management.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.